
Mon. - Thur. 8 am - 5 pm
Sat. - Sun. Closed
816-364-1515

Medisearch Clinical Trials
1427 Village Drive
Saint Joseph. Mo 64506
ATOPIC DERMATITIS

What Is Atopic Dermatitis?
Atopic dermatitis, a type of eczema, is a chronic skin problem that causes dry skin, intense itching, and a red, raised rash. In severe cases, the rash forms clear, fluid-filled blisters. Atopic dermatitis is more common in babies and children, although adults may develop atopic dermatitis, too. It is not clear what causes atopic dermatitis, but people who have the skin problem often have a sensitive immune system and suffer from allergies and asthma.
This is a common skin disease in children. It is so common that people have given it a few names:
-
Eczema (name most people use)
-
Dermatitis
-
Atopic (a-top-ic) eczema
-
Atopic dermatitis
To avoid confusion, we’ll use the medical term atopic dermatitis.
Children often get atopic dermatitis (AD) during their first year of life. If a child gets AD during this time, dry and scaly patches appear on the skin. These patches often appear on the scalp, forehead, and face. These patches are very common on the cheeks.
No matter where it appears, AD is often very itchy. Infants may rub their skin against bedding or carpeting to relieve the itch.
In children of all ages, the itch can be so intense that a child cannot sleep. Scratching can lead to a skin infection.
Source: www.aad.org
ENROLLING NOW
Version1- combined
The purpose of this study is to evaluate the efficacy and safety of the investigational study medication in adults (18-75 years old) and adolescents (12-17 years old) with moderate to severe Atopic Dermatitis, also known as Eczema. The study medication is a tablet and will be taken by mouth.
Who may participate in this study?
You (or your child) may qualify for this research study, if the following applies to you (or your child):
You are between 18-75 years old (or your child is between 12-17 years old)
You (or your child) has moderate to severe Atopic Dermatitis
You/your child are/is experiencing active Atopic Dermatitis symptoms, such as: itchiness, irritated dry skin, redness, etc.
There are other eligibility requirements. A final decision on whether this research study might be suitable for you/your child will be made after you speak with the study doctor at the research site. The study doctor will explain the benefits and risks of participation in this research study.
You may receive reimbursement for your time and travel expenses related to study participation.
Version2- adults
The purpose of this study is to evaluate the efficacy and safety of the investigational study medication in adults (18-75 years old) and adolescents (12-17 years old) with moderate to severe Atopic Dermatitis, also known as Eczema. The study medication is a tablet and will be taken by mouth.
You may qualify for this research study, if the following applies to you (your child):
You are between 18-75 years old
You have moderate to severe Atopic Dermatitis
You are experiencing active Atopic Dermatitis symptoms, such as: itchiness, irritated dry skin, redness,etc.
There are other eligibility requirements. A final decision on whether this research study might be suitable for you will be made after you speak with the study doctor at the research site. The study doctor will explain the benefits and risks of participation in this research study.
You may receive reimbursement for your time and travel expenses related to study participation.
Version3- caregivers
The purpose of this trial is to evaluate the efficacy and safety of the investigational study medication in adolescents (12-17 years old) and adults (18-75 years old) with moderate to severe Atopic Dermatitis, also known as Eczema. The study medication is a tablet and will be taken by mouth.
Your child may be eligible to participate if:
Your child is aged 12 or more years old
Your child has moderate to severe Atopic Dermatitis
Your child is experiencing active Atopic Dermatitis symptoms, such as: itchiness, irritated dry skin,redness, etc.
There are other eligibility requirements. A final decision on whether this research study might be suitable for your child will be made after you and your child speak with the study doctor at the research site. The study doctor will explain the benefits and risks of participation in this research study.
You may receive reimbursement for your time and travel expenses related to study participation.
call 816-364-1515
for more information
GET IN TOUCH
We'd love to hear from you

816-364-1515


